摘要:
The invention relates to the use of strains of the parapox ovis virus as immune therapeutics for infectious or non-infectious immune weaknesses, as well as the use of strains of said virus for treating tumour diseases and viral infections. The invention also relates to the use of strains of the parapox ovis virus for producing pharmaceuticals for both humans and animals.
摘要:
The invention relates to the production and use of organ, tissue and/or cell-specific, recombinant parapox virus ovis as a targeted immuno-therapeutic which is pathogen and organ-specific for treating chronic viral infections and inflammatory, degenerative, proliferative diseases, in particular of the liver and for treating cancer.
摘要:
The invention relates to polynucleotides coding for the PPVO viral genome, to fragments of the polynucleotides coding for the PPVO genome and to polynucleotides coding for individual open reading frames (ORFs) of the PPVO viral genome. The invention also relates to recombinant proteins expressed from the above mentioned polynucleotides and to fragments of said recombinant proteins, and to the use of said recombinant proteins or fragments for the preparation of pharmaceutical compositions.
摘要:
The invention relates to a medicament containing a polyamine as an active substance, in addition to the use of a polyamine for producing immunostimulant medicaments or medicaments for the treatment and/or prophylaxis of various illnesses in humans and animals.
摘要:
The present invention related to use of Parapoxvirus preparations for the treatment of conditions related to infections with strictly intracellular bacteria